Pacific Biosciences of California, Inc. (PACB)

NASDAQ

$2,33

$+0,42

(+22,95%)

Regular Market

Pacific Biosciences of California, Inc. (PACB) Live Price Chart

Last updated: ⁦2026-09-30 15:14:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Pacific Biosciences of California, Inc. (PACB) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $2,33, with a market capitalisation of $531,52M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,07 to $2,73. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$531,52M
Open	$1,84
Day's High	$53,69
Day's Low	$0,85
Previous Close	$1,83
Volume	23,62M
Average Volume	6,87M
P/E Ratio	--
52-Week High	$2,73
52-Week Low	$1,07
Dividend Yield	--
Earnings Date	--

Pacific Biosciences of California, Inc. (PACB) Stock Price Today

Pacific Biosciences of California, Inc. (PACB) is currently trading at $2,33 as of 2026-09-30 14:58:32, up 27,05% ($0,50) from the previous close of $1,83

During today's regular trading session, PACB has traded between $0,85 and $53,69, with a trading volume of 23,62M shares. The current price is near the lower end of today's range.

Pacific Biosciences of California, Inc. (PACB) 7-Day Stock Price Change

Over the past seven days, Pacific Biosciences of California, Inc. (PACB) moved from $1,36 to $2,33, representing a gain of 70,96% ($0,97).

The stock traded between $1,34 and $2,33 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 11,49 million shares, up versus the previous seven-day period, indicating higher trading activity.

PACB 52-Week Price Position

Position in Range: 75,6%

52W Low$1,07

52W High$2,73

PACB is currently trading at $2,33, placing it 75,6% of the way from its 52-week low of $1,07 to its 52-week high of $2,73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Pacific Biosciences of California, Inc. (PACB)?

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

Pacific Biosciences of California, Inc. Information

Industry	LABORATORY ANALYTICAL INSTRUMENTS
Employees	485
Exchange	NASDAQ
Company Website	https://www.pacb.com

How to Buy Pacific Biosciences of California, Inc. (PACB) Stock on MEXC

Eligible investors can buy real shares of Pacific Biosciences of California, Inc. (PACB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PACB and Place Your Order

Open the RealStocks trading page and search for PACB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Pacific Biosciences of California, Inc. (PACB) stock price today?

Pacific Biosciences of California, Inc. (PACB) is currently trading at $ 2,33, up 27,05% ($0,50) from the previous close of $ 1,83. Intraday prices update in real time during regular trading hours.

2.Is PACB stock going up or down today?

As of 2026-09-30 14:58:32, PACB is trading at $ 2,33, up 27,05% ($0,50) from its previous close of $ 1,83. The stock has traded between $ 0,85 and $ 53,69 during today’s regular session. Past price movements do not guarantee future results.

3.What is PACB pre-market price?

As of 2026-09-30 14:58:32, PACB is trading at $ 1,86 in pre-market trading, up 1,37% ($0,02) from the previous close of $ 1,83. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PACB after-hours price?

As of 2026-09-30 14:58:32, PACB is trading at $ 1,83 in after-hours trading, down 0,27% ($0,01) from the regular-session close of $ 1,83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PACB stock trading now?

PACB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PACB sit relative to its 52-week high and low?

Over the past 52 weeks, PACB has traded between a low of $ 1,07 and a high of $ 2,73. At $ 2,33, the stock is positioned 75,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Pacific Biosciences of California, Inc. in?

Pacific Biosciences of California, Inc. (PACB) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Pacific Biosciences of California, Inc.'s market capitalisation and where is it listed?

Pacific Biosciences of California, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 531,52M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PACB valued in terms of P/E ratio and EPS?

PACB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,42. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Pacific Biosciences of California, Inc. pay a dividend?

Pacific Biosciences of California, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.